The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2024
Filed:
Apr. 21, 2022
Applicant:
Yuhan Corporation, Seoul, KR;
Inventors:
Hee Jae Tak, Yongin-si, KR;
Eun Kyung Kim, Seongnam-si, KR;
Hyok Jun Cho, Hwaseong-si, KR;
Cheol Hee Lim, Suwon-si, KR;
Assignee:
Yuhan Corporation, Seoul, KR;
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/14 (2006.01); C07D 257/04 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/10 (2006.01); C07D 409/04 (2006.01); C07D 409/06 (2006.01); C07D 409/14 (2006.01); C07D 413/10 (2006.01); C07D 401/10 (2006.01);
U.S. Cl.
CPC ...
C07D 257/04 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 405/10 (2013.01); C07D 409/04 (2013.01); C07D 409/06 (2013.01); C07D 409/14 (2013.01); C07D 413/10 (2013.01); C07D 401/10 (2013.01);
Abstract
The present technology provides triazolones, tetrazolones, and imidazolones, or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolones, tetrazolones, and imidazolones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).